Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230581
Status:
COMPLETED
Last Update Posted:
2007-10-15
First Post:
2005-09-29
Brief Title:
8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
Sponsor:
Dynogen Pharmaceuticals
Organization:
Dynogen Pharmaceuticals
Organization Data
Organization:
Dynogen Pharmaceuticals
Class:
INDUSTRY
Study ID:
DDP225-04-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dynogen Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None